IP Library Granted Patent US 8,641,732
Granted Patent B1
US 8,641,732 · App. 12/392,955 · Granted Feb 4, 2014

Self-retaining suture with variable dimension filament and method

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,641,732
App. No.
12/392,955
Granted
Feb 4, 2014
Kind
B1
Abstract

A self-retaining suture comprises a variable-dimension filament which varies in size and/or shape along the length of the filament. The variation in size and/or shape results in a variation in the distribution of filament material from one region of the filament to the next. The filament has retainers formed in the surface such that the filament can engage and retain tissue. The retainers are formed in a manner that makes use of regions of the filament where additional material is distributed. The resulting self-retaining suture has a greater minimum cross-section than would be created using an equivalent uniform filament. The resulting self-retaining suture consequently has a greater tensile strength. Methods for manufacturing the filament and retainers are also described.

Claims (17)

1. A surgical suture comprising an elongated filament, the elongated filament comprising:

a plurality of first locations along a length of the elongated filament where a retainer is cut in the filament at each of the first locations, a first filament cross-sectional area present at each of the first locations, where the first filament cross-sectional areas are identical at each of the first locations;

a plurality of second locations interspersed with the plurality of first locations, where a retainer has not been cut in the filament at any of the second locations, a second filament cross-sectional area present at each of the second locations, where the second filament cross sectional areas are identical at each of the second locations;

the first filament cross sectional area being larger than the second filament cross sectional area; and

each retainer having a tissue-penetrating end.

2. The surgical suture of claim 1 which is a degradable suture.

3. The surgical suture of claim 1 which is a non-degradable suture.

4. The surgical suture of claim 1 which is a bidirectional suture.

5. The surgical suture of claim 1 which is a unidirectional suture.

6. The surgical suture of claim 1 in combination with at least one needle.

7. The surgical suture of claim 6 wherein a plurality of retainers are arranged such that the suture can be deployed in the direction of the needle located at a deployment end of the suture but resists movement of the suture in an opposite direction.

8. The surgical suture of claim 1 wherein the retainers lie flat when pulled through tissue in a deployment direction of the suture and fan out when the suture is pulled through tissue in a direction contrary to the deployment direction.

9. The surgical suture of claim 1 having a circular periphery at each of the first and second locations.

10. The surgical suture of claim 1 further comprising a therapeutic composition.

11. The surgical suture of claim 1 further comprising a lubricious agent.

12. The surgical suture of claim 1 fully coated with a therapeutic composition.

13. The surgical suture of claim 1 selectively coated with a therapeutic composition.

Assignments (8)
RELEASE OF SECURITY INTEREST Recorded Apr 12, 2013
From: WELLS FARGO CAPITAL FINANCE, LLC
To: ANGIOTECH PHARMACEUTICALS, INC.; AMERICAN MEDICAL INSTRUMENTS HOLDINGS, INC.; ANGIOTECH AMERICA, INC.; ANGIOTECH BIOCOATINGS CORP.; ANGIOTECH PHARMACEUTICALS (US), INC.; B.G. SULZLE, INC.; MANAN MEDICAL PRODUCTS, INC.; MEDICAL DEVICE TECHNOLOGIES, INC.; QUILL MEDICAL, INC.; SURGICAL SPECIALTIES CORPORATION; ANGIOTECH INTERNATIONAL HOLDINGS CORP.
Reel/Frame 030211/0479 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 27, 2012
From: ANGIOTECH PHARMACEUTICALS, INC.; QUILL MEDICAL, INC.
To: ETHICON, INC.; ETHICON, LLC
Reel/Frame 029294/0443 →
PARTIAL RELEASE OF SECURITY INTERESTS - PATENTS (US) Recorded May 16, 2012
From: WELLS FARGO CAPITAL FINANCE, LLC
To: QUILL MEDICAL, INC.; ANGIOTECH PHARMACEUTICALS, INC.
Reel/Frame 028216/0499 →
PARTIAL RELEASE OF SECURITY INTERESTS - PATENTS (US) Recorded Apr 20, 2012
From: DEUTSCHE BANK NATIONAL TRUST COMPANY
To: QUILL MEDICAL, INC.; ANGIOTECH PHARMACEUTICALS, INC.
Reel/Frame 028078/0699 →
PARTIAL RELEASE OF SECURITY INTEREST - PATENTS Recorded Apr 10, 2012
From: WELLS FARGO CAPITAL FINANCE, LLC
To: QUILL MEDICAL, INC.; ANGIOTECH PHARMACEUTICALS, INC.
Reel/Frame 028022/0861 →
PATENT SECURITY AGREEMENT Recorded May 13, 2011
From: ANGIOTECH PHARMACEUTICALS, INC.; AFMEDICA, INC.; AMERICAN MEDICAL INSTRUMENTS HOLDINGS, INC.; ANGIOTECH AMERICA, INC.; ANGIOTECH BIOCOATINGS CORP.; ANGIOTECH DELAWARE, INC.; ANGIOTECH FLORIDA HOLDINGS, INC.; ANGIOTECH PHARMACEUTICALS (US), INC.; B.G. SULZLE, INC.; MANAN MEDICAL PRODUCTS, INC.; MEDICAL DEVICE TECHNOLOGIES, INC.; NEUCOLL INC.; QUILL MEDICAL, INC.; SURGICAL SPECIALTIES CORPORATION; 0741693 BRITISH COLUMBIA LTD.; ANGIOTECH INTERNATIONAL HOLDINGS, CORP.
To: WELLS FARGO CAPITAL FINANCE, LLC, AS ADMINISTRATIVE AGENT
Reel/Frame 026275/0507 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 7, 2009
From: GORALTCHOUK, ALEXEI; NAIMAGON, ALEXANDER; CUMMINGS, GERALD F.; DRUBETSKY, LEV; HERMANN, ROBERT A.
To: ANGIOTECH PHARMACEUTICALS, INC.
Reel/Frame 022652/0838 →
SECURITY AGREEMENT Recorded Mar 24, 2009
From: ANGIOTECH PHARMACEUTICALS, INC.; AFMEDICA, INC.; AMERICAN MEDICAL INSTRUMENTS HOLDINGS, INC.; ANGIOTECH AMERICA, INC.; ANGIOTECH BIOCOATINGS CORP.; ANGIOTECH CAPITAL, LLC; ANGIOTECH PHARMACEUTICALS (US), INC.; B.G. SULZLE, INC.; CRIMSON CARDINAL CAPITAL, LLC; MANAN MEDICAL PRODUCTS, INC.; MEDICAL DEVICE TECHNOLOGIES, INC.; NEUCOLL, INC.; QUILL MEDICAL, INC.; SURGICAL SPECIALTIES CORPORATION; 0741693 B.C. LTD.; 3091796 NOVA SCOTIA COMPANY; ANGIOTECH INTERNATIONAL HOLDINGS, CORP.; ANGIOTECH INVESTMENT PARTNERSHIP
To: WELLS FARGO FOOTHILL, LLC, AS AGENT
Reel/Frame 022441/0719 →